{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:17:56Z","timestamp":1777508276175,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.expneurol.2006.02.002","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T12:14:10Z","timestamp":1142943250000},"page":"172-183","source":"Crossref","is-referenced-by-count":63,"title":["Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)"],"prefix":"10.1016","volume":"200","author":[{"given":"U.","family":"Yazdani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"German","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-L.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Manzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.K.","family":"Sonsalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.D","family":"Zeevalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.02.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(83)90157-9","article-title":"The crossed mesostriatal projection: neurochemistry and developmental response to lesion","volume":"279","author":"Altar","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0361-9230(91)90242-C","article-title":"Retrograde degeneration of nigrostriatal neurons induced by intrastriatal injection in rats","volume":"26","author":"Berger","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2006.02.002_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(90)91069-S","article-title":"Increased midbrain dopaminergic cell activity following 2\u2032CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study","volume":"527","author":"Bernardini","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2006.02.002_bib5","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","article-title":"Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease","volume":"23","author":"Bizat","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.02.002_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj1340707","article-title":"The mitochondrial generation of hydrogen peroxide","volume":"134","author":"Boveris","year":"1973","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2006.02.002_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004010000247","article-title":"Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei","volume":"101","author":"Braak","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib8","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.02.002_bib9","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin\u2013proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2006.02.002_bib10","first-page":"35","article-title":"The Lewy body in Parkinson's disease","volume":"45","author":"Forno","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-8993(88)91111-0","article-title":"An electron microscopic study of MPTP-induced inclusions bodies in an old monkey","volume":"448","author":"Forno","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","article-title":"In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin and lipids in Lewy bodies","volume":"166","author":"Gai","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.2003.02176.x","article-title":"CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine","volume":"88","author":"Ganguly","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.02.002_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.903310302","article-title":"Midbrain dopaminergic neurons (nuclei A8, A9 and A10): 3-dimensional reconstruction in the rat","volume":"331","author":"German","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","article-title":"1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis. Which midbrain dopaminergic neurons are lost?","volume":"24","author":"German","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2006.02.002_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization","volume":"26","author":"German","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib18","first-page":"1000","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part I: Systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2006.02.002_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib20","first-page":"13","article-title":"Zur pathologischen anatomie des senilen und des parkinsonistichen tremor","volume":"49","author":"Hassler","year":"1939","journal-title":"J. Psychol. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.02.002_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03159727","article-title":"Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse","volume":"10","author":"Heikkila","year":"1989","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.02.002_bib24","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib25","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1983.tb08109.x","article-title":"Amino acids in the substantia nigra of rats with striatal lesions produced by kainic acid","volume":"40","author":"Korf","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.02.002_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2006.02.002_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cne.903320302","article-title":"Leucine-enkephalin afferents to midbrain dopaminergic neurons: light and electron microscopic examination","volume":"332","author":"Liang","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2003.09.075","article-title":"Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neuritis in multiple system atrophy","volume":"354","author":"Lin","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.02.002_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.0022-3042.2002.00744.x","article-title":"Generation of reactive oxygen species by the mitochondrial electron transport chain","volume":"80","author":"Liu","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.02.002_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.02.002_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.parkreldis.2004.01.001","article-title":"A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation","volume":"10","author":"Meredith","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2006.02.002_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0003-9861(92)90498-L","article-title":"Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes","volume":"295","author":"Mithofer","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2006.02.002_bib36","first-page":"307","article-title":"Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"67","author":"Mizukawa","year":"1990","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-8993(97)00584-2","article-title":"Increased dopamine turnover in the putamen after MPTP treatment in common marmosets","volume":"767","author":"Nomoto","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib39","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2006.02.002_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2006.02.002_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(86)90905-4","article-title":"Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment","volume":"376","author":"Ricaurte","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib42","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.biocel.2004.04.009","article-title":"Role of mitochondrial permeability transition pores in mitochondrial autophagy","volume":"36","author":"Rodriguez-Enriquez","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.1710990106","article-title":"Ultrastructural observations in Parkinsonism","volume":"99","author":"Roy","year":"1969","journal-title":"J. Pathol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib44","series-title":"Stress, the Aging Brain, and the Mechanisms of Neuron Death","author":"Sapolsky","year":"1992"},{"key":"10.1016\/j.expneurol.2006.02.002_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine; a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2006.02.002_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.02.002_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-9384(02)00939-3","article-title":"Stress-induced Parkinson's disease: a working hypothesis","volume":"77","author":"Smith","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2006.02.002_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1789.1994.tb00242.x","article-title":"Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-Parkinsonian patient","volume":"14","author":"Takahashi","year":"1994","journal-title":"Neuropathology"},{"key":"10.1016\/j.expneurol.2006.02.002_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00687790","article-title":"Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey","volume":"75","author":"Tanaka","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(00)02960-7","article-title":"Increased striatal dopamine turnover following acute administration of rotenone to mice","volume":"885","author":"Thiffault","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2006.02.002_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.02.002_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.2000.7333","article-title":"Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines","volume":"162","author":"Trimmer","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00002826-198808000-00004","article-title":"Increase of striatal dopamine turnover by stress in MPTP-treated mice","volume":"11","author":"Urakami","year":"1988","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-3940(86)90012-1","article-title":"Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment","volume":"63","author":"Yong","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.02.002_bib56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/ars.2005.7.662","article-title":"Energy status, oxidative stress and ubiquitin proteasomal function during chronic and acute complex I inhibition with rotenone in mesencephalic cultures","volume":"7","author":"Zeevalk","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2006.02.002_bib58","first-page":"870","article-title":"Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition","volume":"257","author":"Zeevalk","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2006.02.002_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/exnr.2002.7917","article-title":"Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum","volume":"176","author":"Zeevalk","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.02.002_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.1992.tb24525.x","article-title":"Neurochemical responses to 6-hydroxydopamine and l-dopa therapy: implications for Parkinson's disease","volume":"648","author":"Zigmond","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T08:20:09Z","timestamp":1586766009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0014488606000574"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.02.002","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}